SCHEMBL7422846

SCHEMBL7422846

CC(C)[C@H](COC=O)NC(=O)C(F)(F)C(=O)C(Cc1ccc(OCc2ccccc2)cc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.44
ITGB3 P05106 4/20 0.43
ITGA2B P08514 4/20 0.43
MME P08473 1/20 0.42
ACE P12821 1/20 0.42
CPA1 P15085 1/20 0.42
ACE2 Q9BYF1 1/20 0.42
CASP3 P42574 2/20 0.42
CASP7 P55210 1/20 0.42
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
CMA1 P23946 1/20 0.41
PPARG P37231 1/20 0.40
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7933938 0.92 CTSD (0.47) CTSDITGB3ITGA2BMMEACE
SCHEMBL8945566 0.92 CTSD (0.47) CTSDITGB3ITGA2BMMEACE
SCHEMBL8945610 0.88 MME (0.45) CTSDITGB3ITGA2BMMEACE
SCHEMBL7421155 0.87 CTSD (0.43) CTSDITGB3ITGA2BMMEACE
SCHEMBL8041651 0.86 MME (0.47) CTSDITGB3ITGA2BMMEACE
SCHEMBL7422223 0.86 ITGB3 (0.45) CTSDITGB3ITGA2BMMEACE
SCHEMBL7425178 0.86 GPR132 (0.44) CTSDITGB3ITGA2BCTSSCTSK
SCHEMBL7417968 0.86 GPR132 (0.44) CTSDCTSSCTSK
SCHEMBL7421246 0.86 GPR132 (0.44) CTSDCTSSCTSK
SCHEMBL8736216 0.85 CTSD (0.53) CTSDITGB3ITGA2BMMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0707564-B1 DIFLUORO STATONE ANALOGS MERRELL PHARMA INC (US) 2000-09-20 EP claimed
EP-0707564-B1 DIFLUORO STATONE ANALOGS MERRELL PHARMA INC (US) 2000-09-20 EP disclosed
US-6114380-A ANTIVIRAL AGENT; ADMINISTERING TO TREAT HIV INFECTION; N-(4-(N-BENZYLOXYCARBONYL-L-VALYL)AMINO-2,2-DIFLUORO-1,3-DIOXO-5-(4-(2-N -MORPHOLYL)ETHYLOXY)PHENYL-PENTYL)-O-((2-PYRIDYL)METHYL)-D-VALINOL, FOR EXAMPLE MERRELL PHARMACEUTICALS INC. (US) 2000-09-05 US disclosed
WO-1995001958-A1 DIFLUORO STATONE ANALOGS MERRELL PHARMACEUTICALS INC. (US) 1995-01-19 WO disclosed